… in COVID-19 represents a therapeutic challenge for clinicians. In this review, we focused on
the role of heparin in various COVID 19 … of treatment with heparin considering its pleiotropic …

… the treatment with heparin and mortality in patients admitted with Covid-19. Routinely recorded,
clinical data, up to the 24th of April 2020, from the 2075 patients with Covid-19, admitted …

… Another group observed that initiation of heparin for 27 patients infected with COVID-19
improved oxygenation; this study did not include a control group (26). Based on these limited …

… sample of patients with COVID-19 hospitalized throughout Italy, shows that heparin use was
… support the use of heparin in in-patients with COVID-19, particularly in severely ill patients. …

… heparin is beneficial in moderately ill patients but not in severely ill patients hospitalized with
COVID-19… trials of therapeutic heparin in moderately ill ward patients with COVID-19, which …

… To accelerate evidence generation, we integrated three platforms evaluating therapeutic-dose
anticoagulation with heparin in patients hospitalized with Covid-19 into a single …

… , mostly with low-molecular-weight heparin (LMWH). So the … with Covid-19, a majority have
involved the use of heparin or … therapeutic heparin as compared with prophylactic heparin or …

… for outcomes reported in available trials of therapeutic heparin compared with usual care
using lower doses of heparin in hospitalized patients with Covid-19. Organ support-free days in …

… Ideally, heparins should be administered to COVID-19 … as soon as possible to heparin/LMWH
to ensure beneficial … during polypharmaceutical treatment of COVID-19. The presence of …

… for Covid-19, therapeutic-dose anticoagulation with heparin … dose anticoagulation with
heparin increased organ support–… to be beneficially influenced by heparin. What defines such a …